The arrythmia monitoring devices market is projected to reach US$ 9,742.95 million by 2028 from US$ 6,212.59 million in 2021; it is expected to grow at a CAGR of 6.6% from 2021 to 2028.

The growth of the arrythmia monitoring devices market is primarily attributed to increase in cardiovascular disease incidence, and surge in geriatric population. Moreover, high product penetration in developing nations is expected to foster the market growth during the forecast period. However, the high cost of products and procedures hinder the market growth. The European economy is severely affected due to the exponential growth of COVID-19 cases. Two consecutive waves of the disease have had devastating effects on economic activities in many countries in the region. The implementation of social distancing and lockdown policies has led to the shuttering of cardiac centers as well as reduction in patient visits to these centers for elective heart treatments. This factor negatively impacted the adoption of arrhythmia monitoring devices in Europe.

The global arrythmia monitoring devices market is segmented on the bases of type, application, and end user. Based on type, the market is segmented into ECG monitors, implantable monitors, Holter monitors, mobile cardiac telemetry, and others. The Holter monitors segment held the largest share of the market in 2020. However, the arrythmia monitoring devices market for the mobile cardiac telemetry segment is anticipated to grow at the highest CAGR during 2021-2028. By application, the market is segmented into bradycardia, tachycardia, atrial fibrillation, ventricular fibrillation, premature contraction, and others. The atrial fibrillation segment held the largest market share in 2020 and is estimated to register the highest CAGR during the forecast period. Based on end user, the arrythmia monitoring devices market is segmented into hospitals and clinics, ambulatory centers, diagnostic centers, and others. The hospitals and clinics segment held the largest share of the market in 2020; however, the ambulatory centers segment is anticipated to register the highest CAGR in the market during the forecast period.

The World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), and American College of Cardiology are among the primary and secondary sources referred to while preparing the report on the arrythmia monitoring devices market.

.